QuVa Pharma Recalls Fentanyl Syringes Due to Glass Particulate Matter
QuVa Pharma is recalling fentanyl syringes due to the potential presence of glass particulate matter. The recall is classified as FDA Class II.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving potential physical contamination like glass particulates in injectable medications.
Plain-English summary
QuVa Pharma, Inc. is recalling fentanyl 1500 mcg/30 mL (50 mcg/mL) 30 mL in 35 mL Syringe Preservative Free. The recall was initiated because the manufacturer recalled the fentanyl active pharmaceutical ingredient (API) due to the potential for glass particulates.
The affected product is distributed nationwide. The recall includes specific lots with expiration dates ranging from November 18, 2019, to December 31, 2019. The FDA has classified this recall as Class II.
Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed in the recall notice. If the product is found, it should be returned to the distributor or manufacturer according to standard recall procedures.
The recalled product
- Product
- fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL in 35 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1099-49
- Manufacturer
- QuVa Pharma, Inc.
- Category
- Drug — Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lots: 10029934 Exp. 11/19/2019
- 10029820 Exp. 11/18/2019
- 10029872 Exp. 11/19/2019
- 10029873 Exp. 11/19/2019
- 10030868 Exp. 11/28/2019
- 10030567 Exp. 11/28/2019
- 10030892 Exp. 12/2/2019
- 10030568 Exp. 11/28/2019
- 10031210 Exp. 12/9/2019
- 10031211 Exp. 12/9/2019
- 10031209 Exp. 12/12/2019
- 10031439 Exp. 12/15/2019
- 10031700 Exp. 12/22/2019
- 10031438 Exp. 12/15/2019
- 10031766 Exp. 12/26/2019
- 10032225 Exp.12/29/2019
- 10032260 Exp. 12/30/2019
- 10032343 Exp. 12/31/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 27 recalled by QuVa Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 27 products in this recall →Related recalls
Same manufacturer · QuVa Pharma, Inc.
See all →- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- HighCompounded pain injection syringes recalled over presence of particulate matter
FDA (Drugs) · 2025-11-05
- HighCompounded Fentanyl and Bupivacaine Epidural Injections Recalled for Sterility Assurance
FDA (Drugs) · 2025-04-02
- HighCompounded Fentanyl-Bupivacaine Epidural Injections Recalled for Sterility Failure
FDA (Drugs) · 2025-04-02
- HighCompounded Fentanyl-Ropivacaine Epidural Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2025-04-02
Same hazard · glass particulate
See all →- SevereTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighProgesterone Injection Recalled for Glass Particulate Matter in Vials
FDA (Drugs) · 2024-08-07
- HighCyanocobalamin Injection Vials Recalled for Glass Particulate Contamination
FDA (Drugs) · 2024-07-24
- HighEye and Ear Dropper Recalled for Potential Glass Particulate Contamination
FDA (Devices) · 2023-06-21